Search results (2)
« Back to NewsDepartment of Oncology to collaborate with Crescendo Biologics
20 September 2019
Department Immunology Research
The Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
Study suggests immune system plays key role in survival after pancreatic cancer surgery
12 February 2019
Researchers in Oxford have found that an individual’s immune system – and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer.